We are live on ! Find out more
AA

AlphaCentric Advisors Portfolio holdings

AUM $118M
This Fund
S&P 500
This Quarter Est. Return
+2.09%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$297M
AUM Growth
+$56.9M
Cap. Flow
+$55.4M
Cap. Flow %
18.67%
Top 10 Hldgs %
80.3%
Holding
232
New
27
Increased
80
Reduced
67
Closed
26

Top Buys

Rank Stock Value
1
MBB icon
iShares MBS ETF
MBB
+$25.2M
2
INVH icon
Invitation Homes
INVH
+$6.9M
3
AMH icon
American Homes 4 Rent
AMH
+$3.4M
4
LAZR
Luminar Technologies
LAZR
+$1.51M
5
LKFT
Lakefront Biotherapeutics American Depositary Shares
LKFT
+$1.34M

Top Sells

Rank Stock Value
1
GMED icon
Globus Medical
GMED
+$978K
2
OMCL icon
Omnicell
OMCL
+$641K
3
ODT
Odonate Therapeutics, Inc. Common Stock
ODT
+$568K
4
RAVN
Raven Industries Inc
RAVN
+$373K
5
NNDM
Nano Dimension
NNDM
+$287K

Sector Composition

Rank Sector Weight
1 Real Estate 18.29%
2 Healthcare 13.15%
3 Technology 2%
4 Industrials 1.37%
5 Consumer Discretionary 1.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TAK icon
201
Takeda Pharmaceutical
TAK
$55.1B
$40K 0.01%
2,200
– –
INSM icon
202
Insmed
INSM
$23.2B
$37K 0.01%
1,100
– –
BFK
203
DELISTED
BlackRock Municipal Income Trust
BFK
$29K 0.01%
1,900
– –
BFY
204
DELISTED
BlackRock New York Municipal Income Trust II
BFY
$26K 0.01%
1,720
– –
BLE
205
DELISTED
BlackRock Municipal Income Trust II
BLE
$23K 0.01%
1,490
– –
BTA
206
DELISTED
BlackRock Long-Term Municipal Advantage Trust
BTA
$22K 0.01%
1,750
– –
ACAD icon
207
Acadia Pharmaceuticals
ACAD
$4.25B
– –
-2,350
Closed -$126K
ADVM
208
DELISTED
Adverum Biotechnologies
ADVM
– –
-1,100
Closed -$119K
ALLO icon
209
Allogene Therapeutics
ALLO
$601M
– –
-5,100
Closed -$129K
ALXO icon
210
ALX Oncology
ALXO
$273M
– –
-1,500
Closed -$129K
ANAB icon
211
AnaptysBio
ANAB
$1.6B
– –
-4,000
Closed -$86K
DVAX
212
DELISTED
Dynavax Technologies
DVAX
– –
-14,500
Closed -$65K
GMED icon
213
Globus Medical
GMED
$10.4B
– –
-15,000
Closed -$978K
GOSS icon
214
Gossamer Bio
GOSS
$66.5M
– –
-15,000
Closed -$145K
ILMN icon
215
Illumina
ILMN
$29.4B
– –
-463
Closed -$167K
IMVT icon
216
Immunovant
IMVT
$8.09B
– –
-2,150
Closed -$99K
LGND icon
217
Ligand Pharmaceuticals
LGND
$6.02B
– –
-1,443
Closed -$90K
LQD icon
218
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$34.7B
– –
-578
Closed -$80K
NKTR icon
219
Nektar Therapeutics
NKTR
$2.39B
– –
-300
Closed -$77K
RCKT icon
220
Rocket Pharmaceuticals
RCKT
$348M
– –
-800
Closed -$44K
TECX
221
Tectonic Therapeutic
TECX
$573M
– –
-1,475
Closed -$247K
VIVS
222
VivoSim Labs
VIVS
$1.46M
– –
-1,667
Closed -$246K
ORTX
223
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
– –
-1,700
Closed -$73K
ICPT
224
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
– –
-4,000
Closed -$99K
KDNY
225
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
– –
-2,500
Closed -$40K
6 7 8
9
10

Similar funds

AIS
Advocate Investing Services Woodbine, Maryland $118M AUM
IVGAI
Index Venture Growth Associates III St. Helier, Channel Islands, Jersey $118M AUM 64.91% 1-Year Est. Return
OIM
Oceanic Investment Management Douglas, Isle Of Man $118M AUM
TIP
Tandem Investment Partners Bordentown, New Jersey $118M AUM 15.76% 1-Year Est. Return
RCG
Ridge Creek Global Strongsville, Ohio $118M AUM
CWM
Capstone Wealth Management Billings, Montana $118M AUM
SPW
Stillwater Private Wealth Glen Mills, Pennsylvania $118M AUM
WLC
Walnut Level Capital Denver, Colorado $118M AUM 59.12% 1-Year Est. Return

AlphaCentric Advisors's Q1 2021 Portfolio in Review

As of Q1 2021, AlphaCentric Advisors held 232 positions worth $297M, up 24% from $240M the previous quarter. Its ten largest holdings account for 80% of the portfolio.

AlphaCentric Advisors deployed $55.4M of net new capital in Q1 2021, opening 27 new positions and adding to 80 existing holdings. Its largest new stake was Luminar Technologies: 3,333 shares worth $1.22M.

By sector, the portfolio is most concentrated in Real Estate at 18% of assets, up from 16% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Omnicell, an estimated $641K trimmed.

  • AlphaCentric Advisors's largest Q1 2021 buy was Luminar Technologies: 3,333 shares worth $1.22M.
  • AlphaCentric Advisors added most to iShares MBS ETF in Q1 2021, an estimated $25.2M increase.
  • AlphaCentric Advisors's biggest Q1 2021 reduction was Omnicell, cutting an estimated $641K.
  • AlphaCentric Advisors fully exited Globus Medical in Q1 2021, selling an estimated $978K.
  • AlphaCentric Advisors's ten largest holdings make up 80% of its $297M portfolio in Q1 2021.
  • AlphaCentric Advisors opened 27 new positions and closed 26 in Q1 2021.
  • AlphaCentric Advisors's portfolio value rose 24% quarter-over-quarter to $297M.

Based on AlphaCentric Advisors's 13F filing for Q1 2021, filed 9 Mar 2022.